Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes

American Journal of Cardiology

Volumn 95, Issue 5, 2005, Pages 675-678

  Veselka, Josef ^a   Duchoňová, Radka ^b   Procházková, Šárka ^b   Páleníčková, Jana ^b   Sorajja, Paul ^b   Tesař, David ^b  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

EID: 13844297635     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.10.050     Document Type: Article

References (19)

1. P. Boekstegers, P. Steinbigler, A. Molnar, M. Schwaiblmair, A. Becker, A. Knez, R. Haberl, G. Steinbeck Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 38 2001 846 853
2. S.M. Chang, N.M. Lakkis, J. Franklin, W.H. Spencer, S.F. Nagueh Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy Circulation 109 2004 824 827
3. S.M. Chang, S.F. Nagueh, W.H. Spencer, N.M. Lakkis Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy J Am Coll Cardiol 42 2003 296 300
4. L. Faber, D. Welge, P. Ziemssen, H. Seggewiss, D. Fassbender, D. Horstkotte Septal ablation for hypertrophic obstructive cardiomyopathy: an analysis of the patients with dissatisfactory reduction of the outflow gradient J Am Coll Cardiol 39 suppl 2002 22B
5. H. Guo, J. Wang, J. Chen, J. Shan, J.-D. Lee, T. Ueda Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and three-year noninvasive follow-up in 18 patients Can J Cardiol 20 2004 779 782
6. N. Lakkis, S. Nagueh, D. Killip, G. Torre, R. Roberts, W. Spencer III Nonsurgical septal reduction for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience J Interv Cardiol 13 2000 157 159
7. W. Mazur, S.F. Nagueh, N.M. Lakkis, K.J. Middleton, D. Killip, R. Roberts, W.H. Spencer Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Circulation 103 2001 1492 1496
8. S. Nagueh, N.M. Lakkis, K. Middleton, D. Killip, W.A. Zoghbi, M.A. Quinones, W.H. Spencer Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 34 1999 1123 1128
9. S.F. Nagueh, N.M. Lakkis, K.J. Middleton, D. Killip, W.A. Zoghbi, M.A. Quinones, W.H. Spencer Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Circulation 99 1999 344 347
10. C.D. Nielsen, D. Killip, W.H. Spencer III Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures Clin Cardiol 26 2003 275 279
11. T.H. Park, N.M. Lakkis, K.J. Middleton, J. Franklin, W.A. Zoghbi, M.A. Quinones, W.H. Spencer, S.F. Nagueh Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy Circulation 106 2002 412 415
12. W. Ruzyllo, L. Chojnowska, M. Demkow, A. Witkowski, B. Kusmierczyk-Droszcz, W. Piotrowski, L. Rausinska, M. Karcz, L. Malecka, W. Rydlewska-Sadowska Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy Eur Heart J 21 2000 770 777
13. H. Seggewiss, L. Faber, U. Gleichmann Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy Thorac Cardiovasc Surg 47 1999 94 100
14. W.G. van Dochum, F.J. ten Cate, J.M. ten Berg, A.M. Beek, J.W. Twisk, J. Vos, M.B. Hofman, C.A. Visser, A.C. van Rossum Myocardial infarction after percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging J Am Coll Cardiol 43 2004 27 34
15. J. Veselka, T. Honěk The management of hypertrophic obstructive cardiomyopathy: the role of percutaneous transluminal septal myocardial ablation Cardiol 9 2000 335 340
16. J. Veselka, T. Honěk Early remodeling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy Int J Cardiol 88 2003 27 32
17. J. Veselka, R. Duchonová, Š Procházková, I. Homolová, J. Páleníçková, D. Zemánek, Z. PerniŠová, D. Tesar The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy Kardiol Pol 60 2004 133 135
18. J. Veselka, Š Procházková, R. Duchonová, I. Bolomová-Homolová, J. Páleníçková, P. Cervinka, D. Tesar, T. Honěk Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome Catheter Cardiovasc Interv 64 2004 231 235
19. T. Lawrenz, F. Lieder, C.J. Leuner, L. Obergassel, B. Gockel, C. Strunk-Mueller, H. Kuhn What is the correct amount of ethanol in the catheter based treatment for hypertrophic obstructive cardiomyopathy? Eur Heart J 24 suppl 2003 136